Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals Misses on EPS, Stock Down 6.35%

Rhythm Pharmaceuticals reported a loss of $0.52 per share, with no revenue figures provided. The stock reacted negatively, dropping 6.35%, likely reflecting investor disappointment in the lack of financial progress and guidance. Without further context from management, the outlook remains uncertain.